Vimarsana
Biggest News Aggregation in the World

Page 20 - Ino News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ino. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ino Today - Breaking & Trending Today

Camry, Land Cruiser maker Toyota cements dominance as world's No 1 seller for fourth year - Vimarsana News

Camry, Land Cruiser maker Toyota cements dominance as world's No 1 seller for fourth year

The Japanese carmaker’s global sales, including those of subsidiaries Daihatsu and Hino, rose 7.2 per cent year on year to a record 11.2 million cars in 2023

Source: scmp.com
Toyota Shipped A Record-Breaking 11.2 Million Cars In 2023 - Vimarsana News

Toyota Shipped A Record-Breaking 11.2 Million Cars In 2023

Toyota is the largest automaker in the world for the fourth year in a row.

5 biggest planned Vinyl Me, Please LP pressings of 2024 - Vimarsana News

5 biggest planned Vinyl Me, Please LP pressings of 2024

The 14,000-square-foot Vinyl Me, Please record-pressing plant in Denver will open in early 2024. Their biggest planned releases include Willie Nelson, John Coltrane, Blue Note and Blue Velvet

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" by StockNews.com - Vimarsana News

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Thursday morning. INO has been the topic of several other research reports. JMP Securities began coverage on Inovio Pharmaceuticals in a research report on Thursday, January 4th. They set a market outperform […]

Inovio Pharmaceuticals (NASDAQ:INO) Lifted to Hold at StockNews.com - Vimarsana News

Inovio Pharmaceuticals (NASDAQ:INO) Lifted to Hold at StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. A number of other equities research analysts have also recently commented on the stock. Oppenheimer raised shares of Inovio Pharmaceuticals from a “market perform” rating to an “outperform” rating and […]